BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

JBIO

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

  • Jade Biosciences doses first participant in Phase 2 JUNIPER trial of JADE101May 26, 2026
  • Jade Biosciences starts Phase 1 trial of JADE101 antibody for IgA nephropathy, eyes 2026 dataSep 2, 2025
  • Jade Biosciences presents promising JADE101 preclinical data for IgA nephropathy at European Renal Association CongressJun 9, 2025
  • Jade Biosciences to present new preclinical data on JADE101 at the 62nd European Renal Association CongressJun 2, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy